$GENI
Genius Sports Ltd

2023 Q4 Form 20-F Financial Statement

#000119312524069118 Filed on March 15, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $127.2M $413.0M
YoY Change 20.73% 21.1%
Cost Of Revenue $116.7M $344.0M
YoY Change 14.2% 1.72%
Gross Profit $10.52M $69.01M
YoY Change 230.07% 2310.23%
Gross Profit Margin 8.27% 16.71%
Selling, General & Admin $36.70M $114.6M
YoY Change -7.78% -25.67%
% of Gross Profit 349.0% 166.07%
Research & Development $7.874M $26.07M
YoY Change 18.16% -12.79%
% of Gross Profit 74.88% 37.78%
Depreciation & Amortization $24.28M $77.31M
YoY Change 41.95% 12.81%
% of Gross Profit 230.91% 112.03%
Operating Expenses $44.57M $143.2M
YoY Change -4.06% -22.22%
Operating Profit -$34.06M -$74.16M
YoY Change -21.3% -59.07%
Interest Expense $7.117M $8.934M
YoY Change -109.3% -225.69%
% of Operating Profit
Other Income/Expense, Net -$110.0K -$9.142M
YoY Change -97.91% -188.33%
Pretax Income -$38.88M -$83.30M
YoY Change -69.33% -53.7%
Income Tax -$423.0K $5.340M
% Of Pretax Income
Net Earnings -$38.45M -$85.53M
YoY Change -69.89% -52.91%
Net Earnings / Revenue -30.24% -20.71%
Basic Earnings Per Share -$0.38
Diluted Earnings Per Share -$0.17 -$0.38
COMMON SHARES
Basic Shares Outstanding 18.50M 208.1M
Diluted Shares Outstanding 208.1M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.3M $100.3M
YoY Change -18.24% -18.24%
Cash & Equivalents $100.3M
Short-Term Investments
Other Short-Term Assets $7.329M $34.56M
YoY Change -82.54% -17.67%
Inventory $347.0K $347.0K
Prepaid Expenses $27.23M
Receivables $71.09M $109.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $244.8M $244.8M
YoY Change 3.49% 3.49%
LONG-TERM ASSETS
Property, Plant & Equipment $11.55M $18.56M
YoY Change -40.27% -4.02%
Goodwill $326.0M
YoY Change 5.2%
Intangibles
YoY Change
Long-Term Investments $26.26M $26.40M
YoY Change 10.87% 11.47%
Other Assets $4.838M $30.30M
YoY Change -86.04% -12.57%
Total Long-Term Assets $530.9M $530.9M
YoY Change -1.09% -1.09%
TOTAL ASSETS
Total Short-Term Assets $244.8M $244.8M
Total Long-Term Assets $530.9M $530.9M
Total Assets $775.7M $775.7M
YoY Change 0.31% 0.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.38M $57.38M
YoY Change 73.24% 73.24%
Accrued Expenses $56.33M $59.94M
YoY Change -6.76% -0.79%
Deferred Revenue $44.30M
YoY Change 7.26%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.573M $7.573M
YoY Change 2.27% 2.27%
Total Short-Term Liabilities $182.9M $182.9M
YoY Change 6.88% 6.88%
LONG-TERM LIABILITIES
Long-Term Debt $19.00K $19.00K
YoY Change -99.73% -99.73%
Other Long-Term Liabilities $936.0K $4.437M
YoY Change -71.5% 35.11%
Total Long-Term Liabilities $955.0K $4.456M
YoY Change -90.79% -57.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $182.9M $182.9M
Total Long-Term Liabilities $955.0K $4.456M
Total Liabilities $202.7M $202.7M
YoY Change 3.15% 3.15%
SHAREHOLDERS EQUITY
Retained Earnings -$1.024B
YoY Change 9.11%
Common Stock $1.646B
YoY Change 4.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $573.0M $573.0M
YoY Change
Total Liabilities & Shareholders Equity $775.7M $775.7M
YoY Change 0.31% 0.31%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$38.45M -$85.53M
YoY Change -69.89% -52.91%
Depreciation, Depletion And Amortization $24.28M $77.31M
YoY Change 41.95% 12.81%
Cash From Operating Activities $24.03M $14.88M
YoY Change 1331.03% -530.56%
INVESTING ACTIVITIES
Capital Expenditures $13.42M $3.569M
YoY Change 8.81% -40.19%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$35.00K $1.573M
YoY Change -105.48% -121.63%
Cash From Investing Activities -$13.45M -$47.57M
YoY Change 15.05% -13.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.000K -596.0K
YoY Change -76.19% 2738.1%
NET CHANGE
Cash From Operating Activities 24.03M 14.88M
Cash From Investing Activities -13.45M -47.57M
Cash From Financing Activities -5.000K -596.0K
Net Change In Cash 10.57M -33.23M
YoY Change -205.3% -47.56%
FREE CASH FLOW
Cash From Operating Activities $24.03M $14.88M
Capital Expenditures $13.42M $3.569M
Free Cash Flow $10.61M $11.31M
YoY Change -199.57% -220.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001834489
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Y7
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Address Country
EntityAddressCountry
GB
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40352
CY2023 dei Entity Registrant Name
EntityRegistrantName
Genius Sports Limited
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Genius Sports Group
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
1st Floor
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
27 Soho Square
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
London
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
W1D 3QR
CY2023 dei Security12b Title
Security12bTitle
Ordinary shares
CY2023 dei Trading Symbol
TradingSymbol
GENI
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18500000
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
true
CY2023 dei Document Fin Stmt Restatement Recovery Analysis Flag
DocumentFinStmtRestatementRecoveryAnalysisFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023 dei Auditor Firm
AuditorFirmId
100
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100331000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122715000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
12102000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
71088000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33378000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
38802000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
38447000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27231000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28207000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7329000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1668000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
244781000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
236517000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11552000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12881000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129670000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
149248000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7011000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6459000
CY2023Q4 us-gaap Goodwill
Goodwill
326011000
CY2022Q4 us-gaap Goodwill
Goodwill
309894000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
26399000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
23682000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
25462000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
24203000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4838000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10453000
CY2023Q4 us-gaap Assets
Assets
775724000
CY2022Q4 us-gaap Assets
Assets
773337000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
57379000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
33121000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56331000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56956000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44345000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41273000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7573000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7405000
CY2022Q4 geni Derivative Warrant Liabilities Current
DerivativeWarrantLiabilitiesCurrent
6922000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3610000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3462000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13676000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22001000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
182914000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
171140000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7088000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15335000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15009000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3501000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3284000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
936000
CY2023Q4 us-gaap Liabilities
Liabilities
202705000
CY2022Q4 us-gaap Liabilities
Liabilities
196521000
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1646082000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1568917000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4105948
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
17653000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1024487000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-938953000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33057000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-55169000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
573019000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576816000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
775724000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
773337000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
412977000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
341029000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262735000
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
343972000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
338166000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
476168000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
11327000
CY2023 us-gaap Gross Profit
GrossProfit
69005000
CY2022 us-gaap Gross Profit
GrossProfit
2863000
CY2021 us-gaap Gross Profit
GrossProfit
-213433000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29432000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31344000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27292000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26070000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29894000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26513000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
85167000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
122829000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
293168000
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2494000
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1668000
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12886000
CY2023 us-gaap Operating Expenses
OperatingExpenses
143163000
CY2022 us-gaap Operating Expenses
OperatingExpenses
185735000
CY2021 us-gaap Operating Expenses
OperatingExpenses
359859000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-74158000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-182872000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-573292000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1953000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1487000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3331000
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-291000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-292000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-46000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2919000
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-218000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19405000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
534000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10132000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11412000
CY2023 geni Loss On Abandonment Of Assets
LossOnAbandonmentOfAssets
11226000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3875000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8979000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3032000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9142000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-408000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31162000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-83300000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-183280000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-604454000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5340000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1714000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11701000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3106000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3358000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-85534000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-181636000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-592753000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-85534000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-85534000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-181636000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-181636000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-604080000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-604080000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.79
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.79
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
225882254
CY2023 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
225882254
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
213391134
CY2022 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
213391134
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
159388360
CY2021 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
159388360
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-85534000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-181636000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-592753000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
22112000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-54996000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11566000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63422000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-236632000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-604319000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-139427000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-592753000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11566000
CY2021 geni Preference Share Accretion
PreferenceShareAccretion
-11327000
CY2021 geni Shares Recapitalized During The Period Value
SharesRecapitalizedDuringThePeriodValue
49938000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
9293000
CY2021 geni Stock Issued During Period Value Equity Offering
StockIssuedDuringPeriodValueEquityOffering
237707000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
110491000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
466306000
CY2021 geni Vesting Of Restricted Shares Value
VestingOfRestrictedSharesValue
1467000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000
CY2021 geni Stock Issued During Period Value Warrant Redemptions
StockIssuedDuringPeriodValueWarrantRedemptions
96416000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
706178000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-181636000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89817000
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
17452000
CY2022 geni Stock Issued During Period Value Warrant Redemptions
StockIssuedDuringPeriodValueWarrantRedemptions
1000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-54996000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
576816000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-85534000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35168000
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10157000
CY2023 geni Stock Issued During Period Value Warrant Redemptions
StockIssuedDuringPeriodValueWarrantRedemptions
14300000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22112000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
573019000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-85534000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-181636000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-592753000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77308000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
68529000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59351000
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-291000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-292000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-46000
CY2023 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2919000
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-218000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19405000
CY2023 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
35318000
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
89839000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
489474000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
534000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10132000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11412000
CY2023 geni Non Cash Interest Expense Income
NonCashInterestExpenseIncome
258000
CY2022 geni Non Cash Interest Expense Income
NonCashInterestExpenseIncome
689000
CY2021 geni Non Cash Interest Expense Income
NonCashInterestExpenseIncome
2444000
CY2023 geni Non Cash Lease Expense
NonCashLeaseExpense
3929000
CY2022 geni Non Cash Lease Expense
NonCashLeaseExpense
6029000
CY2022 geni Gain On Lease Termination
GainOnLeaseTermination
642000
CY2022 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
-281000
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1009000
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
862000
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
808000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-444000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-113000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13409000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2518000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2186000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1465000
CY2023 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
3106000
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
3358000
CY2023 geni Loss On Abandonment Of Assets
LossOnAbandonmentOfAssets
11226000
CY2023 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
-5571000
CY2022 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
5577000
CY2021 us-gaap Difference Between Reported Amount And Reporting Currency Denominated Amount Value
DifferenceBetweenReportedAmountAndReportingCurrencyDenominatedAmountValue
192000
CY2021 geni Increase Decrease In Current Assets Liabilities Due To Effect Of Business Combination
IncreaseDecreaseInCurrentAssetsLiabilitiesDueToEffectOfBusinessCombination
22411000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
33173000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8370000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25771000
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1610000
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
19491000
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
11906000
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8643000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7120000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20563000
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1156000
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4986000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3350000
CY2023 geni Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
1495000
CY2022 geni Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
2122000
CY2021 geni Increase Decrease In Other Assets
IncreaseDecreaseInOtherAssets
1702000
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
22065000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
15743000
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
9577000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3513000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7147000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
20858000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
906000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
14939000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4050000
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1936000
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
12519000
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2218000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3672000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6395000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
916000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-10216000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
557000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14876000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3455000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-63308000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3569000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5967000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6417000
CY2023 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-44158000
CY2022 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-41387000
CY2021 us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-26920000
CY2023 geni Distributions From Contribution To Equity Method Investments
DistributionsFromContributionToEquityMethodInvestments
-1555000
CY2022 geni Distributions From Contribution To Equity Method Investments
DistributionsFromContributionToEquityMethodInvestments
7871000
CY2022 geni Payments To Equity Investments Without Readily Determinable Fair Values
PaymentsToEquityInvestmentsWithoutReadilyDeterminableFairValues
150000
CY2021 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
4738000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1416000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
196000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
25000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
103871000
CY2023 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
18000
CY2022 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
770000
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
176000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47570000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54821000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132319000
CY2021 geni Proceeds From Merger Financing Activities
ProceedsFromMergerFinancingActivities
276341000
CY2021 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
24828000
CY2021 geni Capitalization Of Genius Equity Issuance Costs
CapitalizationOfGeniusEquityIssuanceCosts
20217000
CY2021 geni Pipe Financing Net Of Equity Issuance Costs
PIPEFinancingNetOfEquityIssuanceCosts
-316800000
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
254774000
CY2021 geni Issuance Of B Shares
IssuanceOfBShares
2000
CY2021 geni Payment Towards Preference Shares Payout And Incentive Securities Catchup Adjustment
PaymentTowardsPreferenceSharesPayoutAndIncentiveSecuritiesCatchupAdjustment
313162000
CY2023 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
21000
CY2022 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
21000
CY2021 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
96959000
CY2023 geni Proceeds From Exercise Of Public Warrants
ProceedsFromExerciseOfPublicWarrants
6812000
CY2021 geni Proceeds From Exercise Of Public Warrants
ProceedsFromExerciseOfPublicWarrants
17613000
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7387000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-596000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
410364000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-5061000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4140000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33227000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-63358000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
210597000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159020000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
222378000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11781000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125793000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159020000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
222378000
CY2023 geni Cash Paid Received During The Period Interest
CashPaidReceivedDuringThePeriodInterest
8000
CY2022 geni Cash Paid Received During The Period Interest
CashPaidReceivedDuringThePeriodInterest
798000
CY2021 geni Cash Paid Received During The Period Interest
CashPaidReceivedDuringThePeriodInterest
887000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4490000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2054000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3542000
CY2023 geni Acquisition Of Common Shares By Subsidiary In Connection With Warrant Redemptions
AcquisitionOfCommonSharesBySubsidiaryInConnectionWithWarrantRedemptions
17653000
CY2023 us-gaap Notes Issued1
NotesIssued1
0
CY2022 us-gaap Notes Issued1
NotesIssued1
14688000
CY2023 us-gaap Stock Issued1
StockIssued1
10157000
CY2022 us-gaap Stock Issued1
StockIssued1
17452000
CY2021 geni Redeemable Preferred Shares Accretion
RedeemablePreferredSharesAccretion
11327000
CY2021 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
69272000
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
84664000
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
65876000
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-10-21
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reclassifications </div></div></div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain prior period amounts reported in our consolidated financial statements and notes thereto have been reclassified to conform to current period presentation. </div></div></div>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions reflected in the consolidated financial statements include, but are not limited to, the valuation allowance for deferred tax assets, stock-based compensation including the fair value of equity awards, fair value of warrant liability, fair value estimates of derivatives, allowance for credit losses, revenue recognition, fair value of contingent consideration, purchase price allocation including fair value estimates of intangible assets and goodwill, the estimated useful lives of property and equipment and intangible assets, determination of the incremental borrowing rate to calculate operating lease liabilities and capitalization of internally developed software costs. The Company bases its estimates on historical experience and also on assumptions that it believes are reasonable. Due to the inherent uncertainty involved in making assumptions and estimates, changes in circumstances could result in actual results differing from those estimates, and such differences could be material to the Company’s consolidated balance sheets, statements of operations and comprehensive loss. </div>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div></div><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, and accounts receivable. Some of the amounts held exceed federally insured limits. Management does not believe the Company is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No individual customer accounted for 10% or more of the Company’s accounts receivable as of December 31, 2023 or 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December 31, 2023, two vendors accounted for 58% of the Company’s accounts payable. As of December 31, 2022, one vendor accounted for 44% of the Company’s accounts payable. </div>
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
300000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
300000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1100000
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1000000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1100000
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
900000
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1000000
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
800000
CY2023 geni Percentage Of Unrecognized Tax Benefits To Be Realized For Recognition In The Income Statement
PercentageOfUnrecognizedTaxBenefitsToBeRealizedForRecognitionInTheIncomeStatement
0.50
CY2021Q2 geni Gross Proceeds From The Issuance Of Merger And Other Equity
GrossProceedsFromTheIssuanceOfMergerAndOtherEquity
606300000
CY2021Q2 geni Proceeds From Merger Financing Activities
ProceedsFromMergerFinancingActivities
276300000
CY2021Q2 geni Gross Proceeds From The Issuance Of Equity
GrossProceedsFromTheIssuanceOfEquity
330000000
CY2021Q2 geni Payment Of Stock Issuance Costs And Other Equity Issuances
PaymentOfStockIssuanceCostsAndOtherEquityIssuances
13200000
CY2021Q2 geni Adjustment To Additional Paid In Capital Costs Of Merger
AdjustmentToAdditionalPaidInCapitalCostsOfMerger
20200000
CY2021Q2 geni Adjustment Of Working Capital
AdjustmentOfWorkingCapital
1100000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1700000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
43865000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1126000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
252000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
1000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
5187000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
83800000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
167000
CY2021Q2 us-gaap Goodwill
Goodwill
101411000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
235809000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
273000
CY2021Q2 geni Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
13961000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
6670000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
454000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
16135000
CY2021Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
37493000
CY2021Q2 geni Adjustment Of Working Capital
AdjustmentOfWorkingCapital
1100000
CY2021Q2 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
83800000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
412977000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
341029000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262735000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
412977000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
341029000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262735000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
256800000
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.62
CY2023 geni Revenue Recognized Variable Consideration
RevenueRecognizedVariableConsideration
80900000
CY2022 geni Revenue Recognized Variable Consideration
RevenueRecognizedVariableConsideration
58600000
CY2021 geni Revenue Recognized Variable Consideration
RevenueRecognizedVariableConsideration
38900000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
38800000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
44300000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
38400000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41300000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
21800000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29900000
CY2023 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
400000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
38400000
CY2022 geni Increase Decrease In Contract With Customer Liabilities Due To Payments Received In Advance Of Satisfying Performance Obligations
IncreaseDecreaseInContractWithCustomerLiabilitiesDueToPaymentsReceivedInAdvanceOfSatisfyingPerformanceObligations
3100000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41300000
CY2023 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
40900000
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
27800000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1312000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2993000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2009000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
518000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
667000
CY2023 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
175000
CY2022 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-168000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5136000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2486000
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
26000000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100331000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122715000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25462000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
36305000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125793000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159020000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
20000000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
30000000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25500000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
36300000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
76200000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5100000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
35900000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2500000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2486000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30817000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26953000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19265000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14072000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11552000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12881000
CY2023 us-gaap Depreciation
Depreciation
5100000
CY2022 us-gaap Depreciation
Depreciation
4800000
CY2021 us-gaap Depreciation
Depreciation
3000000
CY2021Q4 us-gaap Goodwill
Goodwill
346418000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
20000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-36544000
CY2022Q4 us-gaap Goodwill
Goodwill
309894000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
16117000
CY2023Q4 us-gaap Goodwill
Goodwill
326011000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
387500000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
257830000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129670000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
324493000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
175245000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
149248000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
72200000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
63800000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56300000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
58683000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
31684000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15293000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8734000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
6621000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8655000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129670000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
26257000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
23548000
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
142000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
134000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
26399000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
23682000
CY2022Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
200000
CY2022 geni Increase Or Decrease In Equity Investments Without Readily Determinable Fair Values
IncreaseOrDecreaseInEquityInvestmentsWithoutReadilyDeterminableFairValues
0
CY2023 geni Increase Or Decrease In Equity Investments Without Readily Determinable Fair Values
IncreaseOrDecreaseInEquityInvestmentsWithoutReadilyDeterminableFairValues
0
CY2022Q4 us-gaap Secured Debt
SecuredDebt
62000
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
7592000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
14493000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7573000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
227000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1385000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
6755000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2023Q4 us-gaap Inventory Net
InventoryNet
347000
CY2022Q4 us-gaap Inventory Net
InventoryNet
283000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7329000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1668000
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1364000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1364000
CY2023Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
CY2022Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
5472000
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1501000
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1779000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Noncurrent
ContractWithCustomerReceivableAfterAllowanceForCreditLossNoncurrent
1973000
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Noncurrent
ContractWithCustomerReceivableAfterAllowanceForCreditLossNoncurrent
1838000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4838000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10453000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
43000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7405000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
19000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7088000
CY2023 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
400000
CY2022 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1500000
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
3400000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7573000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
19000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
7592000
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3041000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
3667000
CY2023Q4 geni Deferred Consideration Current
DeferredConsiderationCurrent
6201000
CY2022Q4 geni Deferred Consideration Current
DeferredConsiderationCurrent
7605000
CY2023Q4 geni Contingent Consideration Current
ContingentConsiderationCurrent
4434000
CY2022Q4 geni Contingent Consideration Current
ContingentConsiderationCurrent
10729000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13676000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22001000
CY2023Q4 geni Contingent Consideration No Current
ContingentConsiderationNoCurrent
420000
CY2022Q4 geni Contingent Consideration No Current
ContingentConsiderationNoCurrent
0
CY2023Q4 geni Deferred Consideration Non Current
DeferredConsiderationNonCurrent
516000
CY2022Q4 geni Deferred Consideration Non Current
DeferredConsiderationNonCurrent
0
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
936000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-85534000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-181636000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-592753000
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2021 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
11327000
CY2023 geni Net Loss Attributable To Common Shareholders Diluted
NetLossAttributableToCommonShareholdersDiluted
85534000
CY2023 geni Net Loss Attributable To Common Shareholders Basic
NetLossAttributableToCommonShareholdersBasic
85534000
CY2022 geni Net Loss Attributable To Common Shareholders Diluted
NetLossAttributableToCommonShareholdersDiluted
181636000
CY2022 geni Net Loss Attributable To Common Shareholders Basic
NetLossAttributableToCommonShareholdersBasic
181636000
CY2021 geni Net Loss Attributable To Common Shareholders Diluted
NetLossAttributableToCommonShareholdersDiluted
604080000
CY2021 geni Net Loss Attributable To Common Shareholders Basic
NetLossAttributableToCommonShareholdersBasic
604080000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
208121980
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
208121980
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198939079
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198939079
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
150912333
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150912333
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
17760274
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
14452055
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
8476027
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
225882254
CY2023 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
225882254
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
213391134
CY2022 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
213391134
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
159388360
CY2021 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
159388360
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.79
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.79
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16587703
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16012787
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16993774
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35318000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
89838000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
489474000
CY2023 geni Contingent Consideration Arrangements Basis For Amount
ContingentConsiderationArrangementsBasisForAmount
404000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
928000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-137973000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-326206000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-84228000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-45307000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-278248000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-83300000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-183280000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-604454000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1260000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4524000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1827000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1708000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5784000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1827000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1708000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13618000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-444000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-113000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
209000
CY2023 geni Deferred Tax Expense Benefit
DeferredTaxExpenseBenefit
-444000
CY2022 geni Deferred Tax Expense Benefit
DeferredTaxExpenseBenefit
-113000
CY2021 geni Deferred Tax Expense Benefit
DeferredTaxExpenseBenefit
-13409000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5340000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1714000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-11701000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.235
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.19
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.19
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.038
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.034
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.016
CY2023 geni Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.02
CY2022 geni Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
0
CY2021 geni Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.004
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.197
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.003
CY2023 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.009
CY2022 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.077
CY2021 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.053
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.311
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.009
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.064
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.02
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
95150000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
95735000
CY2023Q4 geni Deferred Tax Assets Property And Equipment
DeferredTaxAssetsPropertyAndEquipment
-74000
CY2022Q4 geni Deferred Tax Assets Property And Equipment
DeferredTaxAssetsPropertyAndEquipment
-70000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
140906000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
135837000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
269000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
235982000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
231771000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
216988000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
207657000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
18994000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24114000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1911000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1816000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
32418000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
37307000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
34329000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
39123000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
15335000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
15009000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
217000000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
207700000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
195800000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
184300000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
4450000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
5722000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
882000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
444000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
352000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
265000
CY2023 us-gaap Sublease Income
SubleaseIncome
582000
CY2022 us-gaap Sublease Income
SubleaseIncome
1406000
CY2023 us-gaap Lease Cost
LeaseCost
5102000
CY2022 us-gaap Lease Cost
LeaseCost
5025000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
3672000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
6395000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3695000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.013
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3934000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
2629000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1065000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7628000
CY2023Q4 geni Imputed Interest
ImputedInterest
517000
CY2023Q4 geni Present Value Of Lease Liabilities
PresentValueOfLeaseLiabilities
7111000
CY2023 geni Leases Terminated
LeasesTerminated
0
CY2022 geni Leases Terminated
LeasesTerminated
5
CY2023 geni Lease Termination Fees
LeaseTerminationFees
0
CY2022 geni Lease Termination Fees
LeaseTerminationFees
2045000
CY2023 geni Right Of Useassets Derecognized Upon Lease Termination
RightOfUseassetsDerecognizedUponLeaseTermination
0
CY2022 geni Right Of Useassets Derecognized Upon Lease Termination
RightOfUseassetsDerecognizedUponLeaseTermination
4628000
CY2023 geni Lease Liabilities Derecognized Upon Lease Termination
LeaseLiabilitiesDerecognizedUponLeaseTermination
0
CY2022 geni Lease Liabilities Derecognized Upon Lease Termination
LeaseLiabilitiesDerecognizedUponLeaseTermination
5267000
CY2023 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
642000
CY2022Q3 geni Right Of Use Asset Amortized To Salvage Value
RightOfUseAssetAmortizedToSalvageValue
0
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
300000
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
5100000
CY2021 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
2200000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
20000000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
25500000
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
9700000
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
2000000
CY2023 us-gaap Subsequent Event Description
SubsequentEventDescription
no

Files In Submission

Name View Source Status
0001193125-24-069118-index-headers.html Edgar Link pending
0001193125-24-069118-index.html Edgar Link pending
0001193125-24-069118.txt Edgar Link pending
0001193125-24-069118-xbrl.zip Edgar Link pending
d790257d20f.htm Edgar Link pending
d790257dex121.htm Edgar Link pending
d790257dex122.htm Edgar Link pending
d790257dex131.htm Edgar Link pending
d790257dex132.htm Edgar Link pending
d790257dex151.htm Edgar Link pending
d790257dex22.htm Edgar Link pending
d790257dex43.htm Edgar Link pending
d790257dex44.htm Edgar Link pending
d790257dex81.htm Edgar Link pending
d790257dex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g790257dsp040.jpg Edgar Link pending
g790257dsp045.jpg Edgar Link pending
g790257dsp046_1.jpg Edgar Link pending
g790257dsp046_2.jpg Edgar Link pending
g790257dsp048.jpg Edgar Link pending
g790257dsp049_1.jpg Edgar Link pending
g790257dsp049_2.jpg Edgar Link pending
g790257dsp049_3.jpg Edgar Link pending
g790257dsp049_4.jpg Edgar Link pending
g790257g55g55.jpg Edgar Link pending
g790257g56g56.jpg Edgar Link pending
g790257g57g57.jpg Edgar Link pending
g790257g58g01.jpg Edgar Link pending
g790257g58g58.jpg Edgar Link pending
geni-20231231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
geni-20231231_cal.xml Edgar Link unprocessable
geni-20231231_def.xml Edgar Link unprocessable
geni-20231231_lab.xml Edgar Link unprocessable
geni-20231231_pre.xml Edgar Link unprocessable
d790257d20f_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending